What are the contraindications to Perforomist (formoterol fumarate) inhalation solution for nebulization?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraindications to Perforomist (Formoterol Fumarate) Nebulizer Solution

The only absolute contraindication to Perforomist is use in patients with asthma without a concomitant inhaled corticosteroid. 1

Absolute Contraindication

  • Use of formoterol fumarate without an inhaled corticosteroid is contraindicated in patients with asthma 1
  • Perforomist is not indicated for the treatment of asthma at all 1
  • This contraindication stems from FDA safety concerns about long-acting beta-agonists (LABAs) increasing the risk of asthma-related death when used as monotherapy 1

Important Clinical Considerations (Not Absolute Contraindications)

Cardiac Precautions

  • While not contraindicated, use caution in elderly patients with ischemic heart disease, as beta-agonists can cause tachycardia and tremor, which are more common in this population 2
  • Long-term safety data from a 1-year study showed no respiratory deaths in the formoterol group and similar cardiac adverse events compared to placebo (4.1% vs 4.4%) 3
  • Holter monitoring in COPD patients showed no clinically meaningful effects on heart rate, ventricular premature beats, or arrhythmic events compared to placebo 4

Proper Administration Requirements

  • Patients must receive formal instruction on nebulizer use, with the first dose given under supervision 5
  • The nebulizer should be driven by air (not high-flow oxygen) in patients with carbon dioxide retention to avoid worsening hypercapnia 6
  • Treatment typically takes 10 minutes for bronchodilators with a standard volume of 2.0-4.5 mL 5

Common Pitfalls to Avoid

  • Do not confuse with asthma treatment: Perforomist is FDA-approved only for COPD maintenance therapy, not asthma 1
  • Avoid mixing medications without guidance: While beta-agonists and anticholinergics can be mixed together in nebulizers, this should be done only on physician recommendation 2
  • Monitor for tremor: If tremor develops, verify whether the nebulizer contains only formoterol or if it has been mixed with other beta-agonists, as this side effect is dose-dependent 2

References

Guideline

Pulmicort Nebulizer and Tremor Association

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medication Use in Mesh Nebulizers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.